Michael K. Low
Geen lopende functies
Profiel
Mr. Michael K.
Low is Senior Vice President at Valentine Mark Corp.
Mr. Low also served on the board at Cancer Therapeutics, Inc.
Eerdere bekende functies van Michael K. Low
Bedrijven | Functie | Einde |
---|---|---|
Cancer Therapeutics, Inc.
Cancer Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cancer Therapeutics, Inc. is a biotechnology business incubator, with a specific emphasis on disruptive treatments and nanotechnology. It seeks out disruptive cancer research and technology opportunities to invest in, develop and commercialize. It offers therapies, treatments, and pharmaceuticals targeted at more efficiently and effectively attacking cancer. Its development of these life-changing therapies for cancer treatment is achieved through an evolving set of intellectual properties and patents derived from the exploitation of calcium phosphate nanoparticles for therapeutic and diagnostic applications. The company was founded on May 1, 1991 and is headquartered in South Jordan, UT. | Directeur/Bestuurslid | 31-07-2007 |
VALENTINE MARK CORPORATION | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
VALENTINE MARK CORPORATION | Commercial Services |
Bedrijven in privébezit | 1 |
---|---|
Cancer Therapeutics, Inc.
Cancer Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cancer Therapeutics, Inc. is a biotechnology business incubator, with a specific emphasis on disruptive treatments and nanotechnology. It seeks out disruptive cancer research and technology opportunities to invest in, develop and commercialize. It offers therapies, treatments, and pharmaceuticals targeted at more efficiently and effectively attacking cancer. Its development of these life-changing therapies for cancer treatment is achieved through an evolving set of intellectual properties and patents derived from the exploitation of calcium phosphate nanoparticles for therapeutic and diagnostic applications. The company was founded on May 1, 1991 and is headquartered in South Jordan, UT. | Commercial Services |